Multi-Omics Nutritional Approaches Targeting Metabolic-Associated Fatty Liver Disease.
Ontology highlight
ABSTRACT: Currently, metabolic-associated fatty liver disease (MAFLD) is a leading global cause of chronic liver disease, and is expected to become one of the most common indications of liver transplantation. MAFLD is associated with obesity, involving multiple mechanisms such as alterations in lipid metabolism, insulin resistance, hyperinflammation, mitochondrial dysfunction, cell apoptosis, oxidative stress, and extracellular matrix formation. However, the onset and progression of MAFLD is variable among individuals, being influenced by intrinsic (personal) and external environmental factors. In this context, sequence structural variants across the human genome, epigenetic phenomena (i.e., DNA methylation, histone modifications, and long non-coding RNAs) affecting gene expression, gut microbiota d
SUBMITTER: Ramos-Lopez O
PROVIDER: S-EPMC9690481 | biostudies-literature | 2022 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA